Epilepsy Foundation And Alquemie Product Development Group Partner To End Epilepsy

Tuesday, November 20, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

A.P.D.G. to Sell Limited-Edition, Make-Up Trio Starting Black Friday

LANDOVER, Md., Nov. 20, 2018 /PRNewswire/ -- The Epilepsy Foundation and Alquemie Product Development Group (A.P.D.G), a

private label firm and indie cosmetic brand, today announced a partnership to raise awareness about epilepsy, a brain disorder affecting 3.4 million people in the U.S. The partnership includes the sales of a limited-edition, make-up collection created by A.P.D.G. that will raise funds in support of the cause. During the partnership, A.P.D.G will donate 25 percent of their net sales from the product to the Epilepsy Foundation's nationwide campaign "Let's Use Our Brains to End Epilepsy®" to fund research, advocacy and education. The PurpleRouge collection will be sold as a box set on A.P.D.G.'s website starting Black Friday, November 23, 2018. 

"I am truly honored to partner with the Epilepsy Foundation, an organization that has played an integral role in my life while living with epilepsy," said Rhonda M. Davis, founder and chemist of A.P.D.G. "I was diagnosed with epilepsy at the age of 11, and over the years, the Foundation has always been there to provide support and knowledge throughout each phase of my life. Now, it's my time to give back for the fight to End Epilepsy."

Inspired by the colors of the End Epilepsy campaign, PurpleRouge, Davis designed and created the limited edition, make-up collection that includes:

  • Candied Rouge Longwear Liquid Pigment which can be used as lipstick or eyeliner
  • Brain Candy Longwear Cream Pot which can be used as an eyeshadow or body highlighter
  • Electric Reign 10-Free Nontoxic Nail Polish

"We are so excited that A.P.D.G. has teamed up with us to help raise awareness about epilepsy," said Philip M. Gattone, president and CEO of the Epilepsy Foundation. "I'm both impressed and inspired by A.P.D.G.'s commitment to our cause and their creativity in developing the PurpleRouge make-up line. Thanks to their efforts, we'll be able to raise funds, drive more awareness and inspire others to be a part of the fight to End Epilepsy."

A.P.D.G. has also been invited by Teshia L. Lincoln (Coach Smiley), the assistant director and field coordinator of the Orchesis Dance Company of Grambling State University, to debut the product during their televised, Thanksgiving Day halftime performance and additional performances throughout Bayou Classic Weekend in New Orleans, LA (November 22-24, 2018). To purchase the PurpleRouge collection, please visit APDG.co.

About Let's Use Our Brains to End Epilepsy Over a lifetime, 1 in 10 people will have a seizure, and 1 in 26 will be diagnosed with epilepsy. Yet, epilepsy is far more common and less funded than any other brain disorder. To create awareness and inspire action, the Epilepsy Foundation launched Let's Use Our Brains to End Epilepsy to raise awareness about epilepsy and change the conversation around seizures. The campaign is built around the fact that epilepsy can affect anyone with a brain, and anyone with a brain can affect epilepsy. For more information about Let's Use Our Brains to End Epilepsy, please visit EndEpilepsy.org.

About A.P.D.G.A.P.D.G. is a vegan and cruelty-free brand that specializes in long-wear makeup that moves with you. Water, sweat and transfer resistant, A.P.D.G. definitely has you covered. For more information, please visit www.apdg.co.

About the Epilepsy FoundationWith a network of nearly 50 partners throughout the United States, the Foundation connects people to treatment, support and resources; leads advocacy efforts; funds innovative research and the training of specialists; and educates the public about epilepsy and seizure first aid. For more than five decades, the Epilepsy Foundation has shone a light on epilepsy to promote awareness and understanding, and to advocate for laws that matter to people with epilepsy, while also funding $65 million for epilepsy research and supporting 3,076 epilepsy investigators and specialists in their early careers. Over the past 17 years, in partnership with the CDC, the Epilepsy Foundation has helped to improve access to care for people with epilepsy, expanded its digital reach and online resources in homes across the country, and trained more than 500,000 school and community personnel in how to recognize seizures and administer Seizure First Aid. The Foundation has also assisted more than 108,000 people through its 24/7 Helpline in the past five years, and continues to focus on innovation, new therapies, community services, advocacy and education as key priorities. To learn more visit epilepsy.com or call 1.800.332.1000. Follow us on Facebook and Twitter.

Cision View original content:http://www.prnewswire.com/news-releases/epilepsy-foundation-and-alquemie-product-development-group-partner-to-end-epilepsy-300753499.html

SOURCE Epilepsy Foundation



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store